KAIROS PHARMA, LTD. Shares Outstanding (Cover Page)
KAIROS PHARMA, LTD. (KAPA) had Shares Outstanding (Cover Page) of 23.70 million shares as of 2026-08-12, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-12: Entity Common Stock, Shares Outstanding 23.70M shares.
- 2026-05-11: Entity Common Stock, Shares Outstanding 21.41M shares.
- 2026-03-31: Entity Common Stock, Shares Outstanding 21.41M shares.
- 2025-11-14: Entity Common Stock, Shares Outstanding 20.82M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-12 | 23.70M shares 10-Q · filed 2026-08-12 |
| 2026-05-11 | 21.41M shares 10-Q · filed 2026-05-13 |
| 2026-03-31 | 21.41M shares 10-K · filed 2026-03-31 |
| 2025-11-14 | 20.82M shares 10-Q · filed 2025-11-14 |
| 2025-08-11 | 20.74M shares 10-Q · filed 2025-08-12 |
| 2025-07-28 | 20.46M shares 10-K/A · filed 2025-07-28 |
| 2025-05-13 | 16.85M shares 10-Q · filed 2025-05-14 |
| 2025-04-14 | 16.69M shares 10-K/A · filed 2025-04-29 |
| 2024-11-14 | 12.85M shares 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |